1 / 54

AUTOIMMUNITY & THE EYE

AUTOIMMUNITY & THE EYE. THE SEQUEL. For Your Consideration. 30 year-old Caucasian male 12 month history of “progressive restlessness and wild eyes” coworkers accused him of cocaine abuse! referred for drug counseling!. For Your Consideration. Clinical Evaluation violent palpitations

Download Presentation

AUTOIMMUNITY & THE EYE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AUTOIMMUNITY & THE EYE THE SEQUEL

  2. For Your Consideration • 30 year-old Caucasian male • 12 month history of “progressive restlessness and wild eyes” • coworkers accused him of cocaine abuse! • referred for drug counseling!

  3. For Your Consideration • Clinical Evaluation • violent palpitations • unbounded energy • prominent stare • proptosis with 3mm lag • tachycardia • tremor • warm moist hands • 40-g goiter

  4. For Your Consideration • Diagnosis • Graves’ Disease • Thyrotropin (TSH) < 0.1 ulU/mL • T4 = 21 ug/dL • resin T3 uptake (RT3U) = 48%

  5. For Your Consideration • Treatment To Achieve Euthyroid State • Propranolol • Propylthiouracil • radioactive iodine therapy • thyroidectomy

  6. Rheumatoid Arthritis • General Considerations • It’s chronic, systemic, autoimmune and _______! • Onset: insidious, synovial membranes of small joints • females aged 20-40 years • most common cause of physical disability in U.S.

  7. Rheumatoid Arthritis • General Considerations • Genetic and environmental factors • 2.1 million Americans

  8. Rheumatoid Arthritis • General Considerations • Vs Osteoarthritis (degenerative joint disease) • constitutional signs and symptoms • morning stiffness (not helped with rest) • symmetrical

  9. Rheumatoid Arthritis • Criteria For Diagnosis (4/7) • morning stiffness • swelling of joints (2) • symmetrical swelling • subcutaneous nodules • +rheumatoid factor • radiologic evidence • ocular criteria?

  10. Rheumatoid Arthritis • Laboratory Findings • Rheumatoid Factor: IgM against Fc of IgG, more than 75% of patients, non-specific, titers correlate to disease severity • X-rays

  11. Rheumatoid Arthritis • Course and Prognosis • majority in remission within several years • if joint symptoms persist beyond two years: bone deformities, extra-articular manifestations

  12. Rheumatoid Arthritis • Treatment • nonpharmacologic: education, physical therapy, exercise, heat and cold • pharmacologic: NSAID’s, immunosuppressants, antimalarials, gold salts, steroids • DMARD’s = disease modifying anti-rheumatic drugs: methotrexate, hydroxychloroquine, sulfasalizine, leflunomide, prednisone

  13. Rheumatoid Arthritis • Ocular Complications • 25% of patients • anterior > posterior segment • #1 again: KCS • furrowing of peripheral cornea, episleritis / scleritis, peripheral ulcerative keratitis, uveitis in Juvenile Rheumatoid Arthritis

  14. Rheumatoid Arthritis • Ocular Complications • Management • standard • for severe corneal and scleral disease: often > 2 systemic agents

  15. Sjogren’s Syndrome • Basically: • Autoimmune disorder • Causes decreased functioning • Progressive destruction • Salivary & lacrimal glands • Main ocular association: KCS

  16. Sjogren’s Syndrome • General Considerations • 3% of women over age 55 • 1-4 million in US • grossly underdiagnosed autoimmune disease • involves diffuse exocrine gland secretion • sicca complex, arthralgia, fatigue, extraglandular manifestations

  17. Sjogren’s Syndrome • General Considerations • Sicca Complex: dry mouth, nose, vagina • Arthralgia: intermittent and migratory, joints of hands, feet, wrists, ankles, elbows, knees • Pronounced fatigue • Extraglandular problems: skin, nervous system, kidneys, heart, stomach, pancreas • Non-Hodgkin’s Lymphoma: Primary Sjogren’s

  18. Sjogren’s Syndrome • General Considerations • Primary: no collagen vascular disease, 50% • Secondary: rheumatoid arthritis, SLE, scleroderma, dermatomyositis, polymyositis, primary biliary cirrhosis

  19. Sjogren’s Syndrome • Onset • insidious • diagnosis 10 years behind symptoms • instead: psychiatric referral due to lack of knowledge, isolated signs and nature of disease • Many women eventually diagnose themselves!

  20. Sjogren’s Syndrome • Cause • autoimmune lymphocyte / plasma cell infiltration of lacrimal and salivary glands • viral trigger, loss of testosterone

  21. Sjogren’s Syndrome • Diagnosis: what can the O.D. do? • thorough case history on dry eye patients (my patient with Lupus) • water at bedside? • fatigue, arthralgia, dryness of mucosal areas? • Schirmer < 5mm • conjunctival impression cytology

  22. Sjogren’s Syndrome • Diagnosis: Revised International Classification (2002) 4/6 • Ocular symptoms • Oral symptoms • Ocular signs • Histopathology • Salivary gland involvement • serology: anti-Ro (SS-A), anti-La (SS-B), elevated ANA, high RF

  23. Sjorgren’s Syndrome • Differential • Head and neck radiation tx • Hepatitis C • AIDS • Pre-existing lymphoma • Sarcoidosis • Graft vs host disease • Anticholinergic use

  24. Sjogren’s Syndrome • Treatment • older women: humidity, artificial tears and saliva • younger women: NSAID’s, antimalarials, steroids, salagen (stimulates salivary gland production)

  25. Sjogren’s Syndrome • Treatment • Make a difference in a patient’s life! • Support group # 1-800-4-SJOGRENS

  26. Sjogren’s Syndrome • Treatment of “Mackdaddy of Dry Eye” • standard: tears, ointments, plugs, cautery • Filamentary Keratitis:topical steroids, acetylcysteine, NaCl 5%, bandage SCL’s, physical removal

  27. Sjogren’s Syndrome • Treatment of Dry Eye • Cyclosporin A (Restasis, Allergan) • Has met with some success • MOA: cytokine related, anti-ocular surface inflammatory • good safety and tolerability • BID

  28. My Experience With Dry Eye Treatment • What I should consider: severity, instillation, cost, preservatives, viscosity, level of meibomian gland dysfunction, inflammation • Ideally: Refresh  Systane  Restasis • MGD: Refresh Endura

  29. Alcon & Optometry

  30. My Experience With Dry Eye Treatment • Other options: plugs, topical steroids, tetracyclines, omega-3 fatty acids and nutritional supplements, oral secretogogues (Exovac, Salogen) • In Memphis at SCO…COST and SAMPLES, ANTI-INFLAMMATORY RX’s • “Dry eye put off and put on the sidelines”

  31. Graves’ Disease • Introduction • first described by sir Robert James Graves 1835 • treated 3 female patients with goiter, violent palpitations, enlarged eyeballs • at that time, disease thought to be caused by emotional problems

  32. Graves’ Disease • General Considerations • hyperthyroidism, infiltrative ophthalmopathy, infiltrative dermopathy • only cause of hyperthyroidism: significant ophthalmopathy • young to middle-aged female smokers

  33. Graves’ Disease • Etiology and Pathogenesis • IgG autoantibody stimulation of TSH receptors • ophthalmopathy is also autoimmune • shared autoantigen: eye muscle membrane

  34. Graves’ Disease • Diagnosis • clinical presentation • blood thyroid tests: thyrotropin, T3, T4, Free T4, TSIg(thyroid stimulating immunoglobulin), AMA(anti-microsomal antibody), anti-TPO(thyroid peroxidase) antibody • radioactive thyroid uptake: RT3U

  35. Graves’ Disease • Clinical Manifestations • goiter • signs and symptoms consistent with increased metabolic rate: nervousness, insomnia, hyperactivity, emotional liability • “paper shaker” & hot handshake • ophthalmopathy: dry eye, upper lid lag on down gaze, lid retraction, proptosis, diplopia, optic neuropathy

  36. Graves’ Disease • Ophthalmopathy • Keep In Mind…. • severity may not correlate with control • Onset may occur after treatment

  37. Graves’ Disease • Treatment • goals: ease symptoms, make patient euthyroid. hypothyroid • alleviate symptoms: Propranolol (Inderal) • thyroid hormone synthesis blockers: propylthiouracil (PTU), tapazole (methiamazole) • radioactive iodine (several courses)

  38. Graves’ Disease • Treatment • thyroidectomy • may worsen ophthalmopathy without prednisone • cigarette smoking associated with worsening ophthalmopathy

  39. Myasthenia Gravis • General Considerations • autoantibodies against acetylocholine receptors • abnormal fatigueability of muscles under voluntary control • usually orbital and facial muscles

  40. Myasthenia Gravis • General Considerations • prevalence: 1:20,000 • females under 50 / 7:3 • males peak in late 50’s • associated conditions: thymoma and thyroid disease, diabetes, lupus, rheumatoid

  41. Myasthenia Gravis • Signs / Symptoms • majority present with ocular symptoms • ptosis and diplopia, then “spread” • vast majority develop ocular symptoms • variability of ocular fatigue • small percent ocular myasthenia only

  42. Myasthenia Gravis • Recall of Residency Patient • Ptosis OD • Visit several months earlier, ptosis OS • The other resident just made a mistake

  43. Myasthenia Gravis • Signs / Symptoms • Non-Ocular • limb fatigue • facial muscle weakness: difficulty breathing, chewing, talking, swallowing

  44. Myasthenia Gravis • Signs / Symptoms • Ocular • worse at end of day • ptosis, orbicularis weakness, virtually any motility defect with diplopia • Cogan’s lid twitch, exposure keratitis • pupil is never involved

  45. Mysathenia Gravis • Diagnosis • Optometric • history • measure palpebral apertures • pupils • sustained up gaze • squeezing closed of eyelids • diplopia without ptosis

  46. Myasthenia Gravis • Diagnosis • Optometric • Ice Pack Test: > 5 minutes, improves neuromuscular transmission, complete ptosis?, safe speedy and easy with relatively high sensitivity and specificity • Sleep Test: eyes closed for 30 minutes • Family Album Topography (FAT) Scan

  47. Myasthenia Gravis • Diagnosis • Referral: Neurologist / Neuroophthalmologist • Endrophonium HCL (Tensilon): IV 10 mg of Tensilon, monitor heart rate, BP, eyelid or motility defect, anti-cholinesterase, rate of complications very low but life threatening

  48. Myasthenia Gravis • Diagnosis • Referral • Tensilon Complications: severe hypotension, bradycardia, cardiac arrest, respiratory arrest, seizures, vomiting • Appropriate resuscitation equipment • EMG (electromyography) • Acetylcholine antibody receptor test

  49. Myasthenia Gravis • Management • lid crutches and tape • occlusion • rarely prism, ptosis or strabismus therapy • Lab testing for associated conditions • CT scan of chest / mediastinum: thymoma

  50. Myasthenia Gravis • Management • anticholinesterases, steroids, immunosuppressants, thymectomy • plasmapharesis, IV gammaglobulin

More Related